Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
US6824777B1 · kind B1 · utility
26Cited by
28References
54Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 9, 1998 |
| Grant date | Nov 30, 2004 |
| Priority date | — |
| Expiry date | Oct 9, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provide purified Flt4 receptor tyrosine kinase polypeptides and fragments thereof, polynucleotides encoding such polypeptides, antibodies that specifically bind such polypeptides, and uses therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.